MetaCap

Ocugen (OCGN) News

NASDAQ: OCGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.7679+0.0351 (+4.79%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

OCGN news summary

We found 7 recent headlines mentioning Ocugen (OCGN): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, OCGN is up 4.79% at $0.7679. The most recent story, "Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN", was published by GlobeNewswire on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Ocugen headlines

Stocks mentioned alongside OCGN

Compare OCGN